Concepedia

Author

Michiru Sawahata

Jichi Medical UniversityORCID

Also Known As

M Sawahata, M. Sawahata, Michiru Sawahata

40

Publications

620

Citations

11

H-Index

25

Concepts

All Affiliations

Jichi Medical UniversitySaiseikai Utsunomiya hospitalNational Hospital OrganizationDokkyo Medical UniversityJichi Medical University Hospital
MS

About

Michiru Sawahata is an author at Jichi Medical University specializing in epidemiology, clinical epidemiology, and public health.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Public Health

5

5

209

2

Epidemiology

5

5

209

3

Medicine

3

3

67

4

Immunology

2

2

44

5

Allergy

1

1

15

Michiru Sawahata

×

13

Publications

520

Citations

11

H-Index

YearCitations

Pathological differentiation of chronic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis/usual interstitial pneumonia

Tamiko Takemura, Takumi Akashi, Hiroyuki Kamiya,

Histopathology

2012

119

Age and Smoking Predict Antibody Titres at 3 Months after the Second Dose of the BNT162b2 COVID-19 Vaccine

Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura,

Vaccines

2021

88

Age-related and historical changes in the clinical characteristics of sarcoidosis in Japan

Michiru Sawahata, Yukihiko Sugiyama, Yosikazu Nakamura,

Respiratory Medicine

2015

81

The impact of demographic disparities in the presentation of sarcoidosis: A multicenter prospective study

Ying Zhou, Alicia K. Gerke, Elyse E. Lower,

Respiratory Medicine

2021

61

Attenuation of Antibody Titers from 3 to 6 Months after the Second Dose of the BNT162b2 Vaccine Depends on Sex, with Age and Smoking Risk Factors for Lower Antibody Titers at 6 Months

Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura,

Vaccines

2021

31

Computed Tomography Images of Fibrotic Pulmonary Sarcoidosis Leading to Chronic Respiratory Failure

Michiru Sawahata, Takeshi Johkoh, Takeshi Kawanobe,

Journal of Clinical Medicine

2020

30

Age and smoking predict antibody titres at 3 months after the second dose of the BNT162b2 COVID-19 vaccine

Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura,

2021

29

An epidemiological perspective of the pathology and etiology of sarcoidosis.

Michiru Sawahata, Yukihiko Sugiyama

PubMed

2016

23

Attenuation of antibody titres during 3-6 months after the second dose of the BNT162b2 vaccine depends on sex, with age and smoking as risk factors for lower antibody titres at 6 months

Yushi Nomura, Michiru Sawahata, Yosikazu Nakamura,

2021

15

Imaging Findings of Fibrosis in Pulmonary Sarcoidosis.

Michiru Sawahata, Tetsuo Yamaguchi

PubMed

2022

12

Page 1